These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2358361)

  • 1. Hiroshima and Nagasaki: new doses, risks, and their implications.
    Schull WJ; Shimizu Y; Kato H
    Health Phys; 1990 Jul; 59(1):69-75. PubMed ID: 2358361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the Hiroshima and Nagasaki survivors, and their use in estimating radiation risks.
    Muirhead CR
    Radiat Prot Dosimetry; 2003; 104(4):331-5. PubMed ID: 14579889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to ionizing radiation and development of bone sarcoma: new insights based on atomic-bomb survivors of Hiroshima and Nagasaki.
    Samartzis D; Nishi N; Hayashi M; Cologne J; Cullings HM; Kodama K; Miles EF; Funamoto S; Suyama A; Soda M; Kasagi F
    J Bone Joint Surg Am; 2011 Jun; 93(11):1008-15. PubMed ID: 21984980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of circular asymmetry in cancer mortality of Hiroshima and Nagasaki A-bomb survivors.
    Peterson AV; Prentice RL; Ishimaru T; Kato H; Mason M
    Radiat Res; 1983 Jan; 93(1):184-99. PubMed ID: 6823505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer risk among atomic bomb survivors. The RERF Life Span Study. Radiation Effects Research Foundation.
    Shimizu Y; Schull WJ; Kato H
    JAMA; 1990 Aug; 264(5):601-4. PubMed ID: 2366300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new assessment of the data from Hiroshima and Nagasaki].
    Kellerer AM
    Strahlenschutz Forsch Prax; 1988; 30():63-91. PubMed ID: 3222810
    [No Abstract]   [Full Text] [Related]  

  • 7. [Radiation risks. Results of the new evaluation].
    Kellerer AM
    Radiologe; 1991 May; 31(5):227-34. PubMed ID: 1876693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary gland tumors among atomic bomb survivors, 1950-1987.
    Saku T; Hayashi Y; Takahara O; Matsuura H; Tokunaga M; Tokunaga M; Tokuoka S; Soda M; Mabuchi K; Land CE
    Cancer; 1997 Apr; 79(8):1465-75. PubMed ID: 9118025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of meningioma among Hiroshima atomic bomb survivors.
    Shintani T; Hayakawa N; Hoshi M; Sumida M; Kurisu K; Oki S; Kodama Y; Kajikawa H; Inai K; Kamada N
    J Radiat Res; 1999 Mar; 40(1):49-57. PubMed ID: 10408177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of death among children of atomic bomb survivors after 62 years of follow-up: a cohort study.
    Grant EJ; Furukawa K; Sakata R; Sugiyama H; Sadakane A; Takahashi I; Utada M; Shimizu Y; Ozasa K
    Lancet Oncol; 2015 Oct; 16(13):1316-23. PubMed ID: 26384241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Did atomic bomb radiation influence the incidence of retinoblastoma in Nagasaki and Hiroshima?
    Amemiya T; Takano J; Choshi K
    Ophthalmic Paediatr Genet; 1993 Jun; 14(2):75-9. PubMed ID: 8233356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1980.
    Tokunaga M; Land CE; Yamamoto T; Asano M; Tokuoka S; Ezaki H; Nishimori I
    Radiat Res; 1987 Nov; 112(2):243-72. PubMed ID: 3685255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of cancer risk by ionizing radiation after dosimetry revision of Hiroshima and Nagasaki].
    Breckow J
    Med Klin (Munich); 1991 Feb; 86(2):92-8. PubMed ID: 2030666
    [No Abstract]   [Full Text] [Related]  

  • 14. Radiation exposure and thyroid cancer incidence among Hiroshima and Nagasaki residents.
    Prentice RL; Kato H; Yoshimoto K; Mason M
    Natl Cancer Inst Monogr; 1982; 62():207-12. PubMed ID: 7167191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid Dysfunction and Autoimmune Thyroid Diseases Among Atomic Bomb Survivors Exposed in Childhood.
    Imaizumi M; Ohishi W; Nakashima E; Sera N; Neriishi K; Yamada M; Tatsukawa Y; Takahashi I; Fujiwara S; Sugino K; Ando T; Usa T; Kawakami A; Akahoshi M; Hida A
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2516-2524. PubMed ID: 28472357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrons at Hiroshima: how their disappearance affected risk estimates.
    Ellett WH
    Radiat Res; 1991 Oct; 128(1 Suppl):S147-52. PubMed ID: 1924742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950-69.
    McGregor H; Land CE; Choi K; Tokuoka S; Liu PI; Wakabayashi T; Beebe GW
    J Natl Cancer Inst; 1977 Sep; 59(3):799-811. PubMed ID: 894745
    [No Abstract]   [Full Text] [Related]  

  • 18. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Tumor registries and cancer incidence studies.
    Mabuchi K; Soda M
    J Radiat Res; 1991 Mar; 32 Suppl():239-44. PubMed ID: 1762111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74.
    Tokunaga M; Norman JE; Asano M; Tokuoka S; Ezaki H; Nishimori I; Tsuji Y
    J Natl Cancer Inst; 1979 Jun; 62(6):1347-59. PubMed ID: 286106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.